Evaluation of magnetic resonance diffusion and spectroscopy measurements as predictive biomarkers in stage 1 cervical cancer

Gynecologic Oncology

Volumn 116, Issue 2, 2010, Pages 246-252

  Payne, Geoffrey S ^a   Schmidt, Maria ^a   Morgan, Veronica A ^a   Giles, Sharon ^a   Bridges, Jane ^b   Ind, Thomas ^b   deSouza, Nandita M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

ADC; Cervix; Choline; Diffusion; Magnetic resonance spectroscopy; MRI

Indexed keywords

BIOLOGICAL MARKER; CHOLINE; TOTAL CHOLINE; UNCLASSIFIED DRUG;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CELL TYPE; DIFFUSION COEFFICIENT; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; TUMOR DIFFERENTIATION; TUMOR VOLUME; UTERINE CERVIX CANCER;

ADULT; AGED; CELL DIFFERENTIATION; CHOLINE; COHORT STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 74249122968     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.09.044     Document Type: Article

References (28)

1. Heatley M.K. Systematic review and meta-analysis in anatomic pathology: the value of nuclear DNA content in predicting progression in low grade CIN, the significance of the histological subtype on prognosis in cervical carcinoma. Histol. Histopathol. 14 1 (1999 Jan) 203-215
2. Takeuchi M., Sasaki S., Ito M., Okada S., Takahashi S., Kawai T., et al. Urinary bladder cancer: diffusion-weighted MR imaging-accuracy for diagnosing T stage and estimating histologic grade. Radiology 251 1 (2009 Apr) 112-121
3. Murakami R., Hirai T., Sugahara T., Fukuoka H., Toya R., Nishimura S., et al. Grading astrocytic tumors by using apparent diffusion coefficient parameters: superiority of a one- versus two-parameter pilot method. Radiology 251 3 (2009 Jun) 838-845
4. Alvarez-Linera J., Benito-Leon J., Escribano J., and Rey G. Predicting the histopathological grade of cerebral gliomas using high b value MR DW imaging at 3-tesla. J. Neuroimaging 18 3 (2008 Jul) 276-281
5. Messiou C., Morgan V.A., De Silva S.S., Ind T.E., and deSouza N.M. Diffusion weighted imaging of the uterus: regional ADC variation with oral contraceptive usage and comparison with cervical cancer. Acta Radiol. 50 6 (2009 Jul) 696-701
6. Charles-Edwards E.M., Messiou C., Morgan V.A., De Silva S.S., McWhinney N.A., Katesmark M., et al. Diffusion-weighted imaging in cervical cancer with an endovaginal technique: potential value for improving tumor detection in stage Ia and Ib1 disease. Radiology 249 2 (2008 Nov) 541-550
7. Glunde K., Jacobs M.A., and Bhujwalla Z.M. Choline metabolism in cancer: implications for diagnosis and therapy. Expert Rev. Mol. Diagn. 6 6 (2006 Nov) 821-829
8. Sardanelli F., Fausto A., and Podo F. MR spectroscopy of the breast. Radiol. Med. 113 1 (2008 Feb) 56-64
9. Zakian K.L., Shukla-Dave A., Ackerstaff E., Hricak H., and Koutcher J.A. 1H magnetic resonance spectroscopy of prostate cancer: biomarkers for tumor characterization. Cancer Biomark. 4 4-5 (2008) 263-276
10. Schwarz A.J., Maisey N.R., Collins D.J., Cunningham D., Huddart R., and Leach M.O. Early in vivo detection of metabolic response: a pilot study of 1H MR spectroscopy in extracranial lymphoma and germ cell tumours. Br. J. Radiol. 75 900 (2002 Dec) 959-966
11. Haddadin I.S., McIntosh A., Meisamy S., Corum C., Styczynski Snyder A.L., Powell N.J., et al. Metabolite quantification and high-field MRS in breast cancer. NMR Biomed. 22 1 (2009 Jan) 65-76
12. Kimura T., Sako K., Tanaka K., Gotoh T., Yoshida H., Aburano T., et al. Evaluation of the response of metastatic brain tumors to stereotactic radiosurgery by proton magnetic resonance spectroscopy, 201TlCl single-photon emission computerized tomography, and gadolinium-enhanced magnetic resonance imaging. J. Neurosurg. 100 5 (2004 May) 835-841
13. De Silva S.S., Payne G.S., Thomas V., Carter P.G., Ind T.E., and deSouza N.M. Investigation of metabolite changes in the transition from pre-invasive to invasive cervical cancer measured using (1)H and (31)P magic angle spinning MRS of intact tissue. NMR Biomed. 22 2 (2009 Feb) 191-198
14. De Silva S.S., Payne G.S., Morgan V.A., Ind T.E., Shepherd J.H., Barton D.P., et al. Epithelial and stromal metabolite changes in the transition from cervical intraepithelial neoplasia to cervical cancer: an in vivo 1H magnetic resonance spectroscopic imaging study with ex vivo correlation. Eur. Radiol. 19 8 (2009 Aug) 2041-2048
15. DeSouza N.M., Scoones D., Krausz T., Gilderdale D.J., and Soutter W.P. High-resolution MR imaging of stage I cervical neoplasia with a dedicated transvaginal coil: MR features and correlation of imaging and pathologic findings. AJR Am. J. Roentgenol. 166 3 (1996 Mar) 553-559
16. Star-Lack J., Nelson S.J., Kurhanewicz J., Huang L.R., and Vigneron D.B. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn. Reson. Med. 38 2 (1997 Aug) 311-321
17. Delakis I., Moore E.M., Leach M.O., and De Wilde J.P. Developing a quality control protocol for diffusion imaging on a clinical MRI system. Phys. Med. Biol. 49 8 (2004 Apr 21) 1409-1422
18. Provencher S.W. Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed. 14 4 (2001 Jun) 260-264
19. Slaton J.W., Morgenstern N., Levy D.A., Santos Jr. M.W., Tamboli P., Ro J.Y., et al. Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal lymph node metastasis in penile squamous cancer. J. Urol. 165 4 (2001 Apr) 1138-1142
20. La R.S., Klersy C., Uccella S., Dainese L., Albarello L., Sonzogni A., et al. Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Hum. Pathol. 40 1 (2009 Jan) 30-40
21. Deshpande A.H., Kotwal M.N., and Bobhate S.K. Glassy cell carcinoma of the uterine cervix a rare histology. Report of three cases with a review of the literature. Indian J. Cancer 41 2 (2004 Apr) 92-95
22. Son H.J., Song S.Y., Lee W.Y., Yang S.S., Park S.H., Yang M.H., et al. Characteristics of early colorectal carcinoma with lymph node metastatic disease. Hepatogastroenterology 55 85 (2008 Jul) 1293-1297
23. Bilimoria K.Y., Bentrem D.J., Rock C.E., Stewart A.K., Ko C.Y., and Halverson A. Outcomes and prognostic factors for squamous-cell carcinoma of the anal canal: analysis of patients from the National Cancer Data Base. Dis. Colon Rectum 52 4 (2009 Apr) 624-631
24. Milliken D.A., and Shepherd J.H. Fertility preserving surgery for carcinoma of the cervix. Curr. Opin. Oncol. 20 5 (2008 Sep) 575-580
25. deSouza N.M., Dina R., McIndoe G.A., and Soutter W.P. Cervical cancer: value of an endovaginal coil magnetic resonance imaging technique in detecting small volume disease and assessing parametrial extension. Gynecol. Oncol. 102 1 (2006 Jul) 80-85
26. deSouza N.M., McIndoe G.A., Soutter W.P., Krausz T., Chui K.M., Hughes C., et al. Value of magnetic resonance imaging with an endovaginal receiver coil in the pre-operative assessment of Stage I and IIa cervical neoplasia. Br. J. Obstet. Gynaecol. 105 5 (1998 May) 500-507
27. Gilderdale D.J., deSouza N.M., Coutts G.A., Chui M.K., Larkman D.J., Williams A.D., et al. Design and use of internal receiver coils for magnetic resonance imaging. Br. J. Radiol. 72 864 (1999 Dec) 1141-1151
28. Huang H., Ceritoglu C., Li X., Qiu A., Miller M.I., van Zijl P.C., et al. Correction of B0 susceptibility induced distortion in diffusion-weighted images using large-deformation diffeomorphic metric mapping. Magn. Reson. Imaging 26 9 (2008 Nov) 1294-1302